{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:24:06Z","timestamp":1793921046941,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154495","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:59:24Z","timestamp":1789365564000},"page":"154495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Circulating exosomal long non-coding RNAs NAMPT-Antisense and SNHG5 as emerging biomarkers in breast cancer"],"prefix":"10.1016","volume":"382","author":[{"given":"Sara M.","family":"Abdeljalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherihan G.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Ghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montaser Bellah","family":"Yasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5102-3235","authenticated-orcid":false,"given":"Dina H.","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154495_bb0005","unstructured":"L.M. Ervik M, Lam F, Colombet M, Ferlay J, Filho AM, Bray F., Global Cancer Observatory: Cancer Today (2024 estimates, version 1.0). Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/today, accessed [01 September 2026]. (2026)."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154495_bb0010","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0015","first-page":"151","article-title":"Epidemiological characteristics of and risk factors for breast cancer in the world","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154495_bb0020","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154495_bb0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11\u221212","key":"10.1016\/j.ijbiomac.2026.154495_bb0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/hum.2023.074","article-title":"Long non-coding RNAs, cell cycle, and human breast cancer","volume":"34","author":"Yin","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0035","article-title":"Long non-coding RNAs as potential diagnostic and prognostic biomarkers in breast cancer: progress and prospects","volume":"11 - 2021","author":"Lu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138589","article-title":"New insights of LncRNAs fingerprints in breast cancer progression: tumorigenesis, drug resistance, and therapeutic opportunities","volume":"287","author":"Hussen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154495_bb0045","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00018-019-03018-3","article-title":"The functional roles of exosomal long non-coding RNAs in cancer","volume":"76","author":"Wang","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010286","article-title":"Decoding roles of exosomal lncRNAs in tumor-immune regulation and therapeutic potential","volume":"15","author":"Zhang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.738945","article-title":"Tumor-derived exosomal non-coding RNAs: the emerging mechanisms and potential clinical applications in breast cancer","volume":"11","author":"Yi","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154495_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092566","article-title":"Exosomes: a source for new and old biomarkers in cancer","volume":"12","author":"Logozzi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0065","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154495_bb0070","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","article-title":"The role of extracellular vesicles in cancer","volume":"186","author":"Kalluri","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-021-06474-3","article-title":"Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA)","volume":"192","author":"Morasso","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106189","article-title":"NAMPT: a critical driver and therapeutic target for cancer","volume":"145","author":"Gasparrini","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0085","article-title":"Beyond energy metabolism: exploiting the additional roles of NAMPT for cancer therapy","volume":"9","author":"Heske","year":"2019","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154495_bb0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and pathophysiological roles of NAMPT and NAD metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107509","article-title":"Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy","volume":"149","author":"Ozgencil","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154495_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092059","article-title":"Updated functional roles of NAMPT in carcinogenesis and therapeutic niches","volume":"14","author":"Lin","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154495_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020297","article-title":"The Adipokine Visfatin modulates cancer stem cell properties in triple-negative breast cancer","volume":"11","author":"Chiang","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154495_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.895","article-title":"Comparison of visfatin levels in patients with breast cancer and endometrial cancer with healthy individuals: a systematic review and meta-analysis","volume":"5","author":"Ghaneialvar","year":"2022","journal-title":"Health Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3892\/or.2015.4391","article-title":"Biomarker triplet NAMPT\/VEGF\/HER2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer","volume":"35","author":"Zhu","year":"2016","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0120","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1186\/s12885-019-6221-0","article-title":"Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin","volume":"19","author":"Bolandghamat Pour","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00656","article-title":"Recent advances in NAMPT inhibitors: a novel immunotherapic strategy","volume":"11","author":"Galli","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.154495_bb0130","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1158\/0008-5472.CAN-18-3418","article-title":"Epigenetic regulation of NAMPT by NAMPT-ASDrives metastatic progression in triple-negative breast cancer","volume":"79","author":"Zhang","year":"2019","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154495_bb0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020035836","article-title":"Prognostic value of differentially expressed LncRNAs in triple-negative breast cancer: a systematic review and meta-analysis","volume":"30","author":"Tuluhong","year":"2020","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122850","article-title":"Revealing the role of serum exosomal novel long non-coding RNA NAMPT-AS as a promising diagnostic\/prognostic biomarker in colorectal cancer patients","volume":"352","author":"Rizk","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144724","article-title":"LncRNA SNHG5: a new budding star in human cancers","volume":"749","author":"Li","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0150","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.2147\/OTT.S252750","article-title":"Latest advances of long non-coding RNA SNHG5 in human cancers","volume":"13","author":"Han","year":"2020","journal-title":"Onco. Targets. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154495_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41374-020-00519-9","article-title":"LncRNA SNHG5 upregulation induced by YY1 contributes to angiogenesis via miR-26b\/CTGF\/VEGFA axis in acute myelogenous leukemia","volume":"101","author":"Li","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.omtn.2019.05.013","article-title":"SNHG5 promotes breast cancer proliferation by sponging the miR-154-5p\/PCNA Axis","volume":"17","author":"Chi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154495_bb0165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/dna.2022.0214","article-title":"MicroRNA-26b reduces cell viability by inhibition of nicotinamide phosphoribosyltransferase in breast cancer cells","volume":"41","author":"Ameli Mojarad","year":"2022","journal-title":"DNA Cell Biol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.154495_bb0170","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154495_bb0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154495_bb0180","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.154495_bb0185","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-College of American pathologists guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154495_bb0190","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies--improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154495_bb0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154495_bb0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4274\/ejbh.galenos.2021.2021-4-3","article-title":"American joint committee on cancer\u2019s staging system for breast cancer, eighth edition: summary for clinicians","volume":"17","author":"Zhu","year":"2021","journal-title":"Eur. J. Breast Health"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154495_bb0205","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154495_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4939-7253-1_18","article-title":"Detection and characterization of extracellular vesicles by transmission and cryo-transmission electron microscopy","volume":"1660","author":"Cizmar","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-0716-3203-1_4","article-title":"Characterization of extracellular vesicles by transmission electron microscopy and immunolabeling electron microscopy","volume":"2668","author":"Corona","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154495_bb0230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cyto.a.24193","article-title":"Evaluation of exosome proteins by on-bead flow cytometry","volume":"99","author":"Theodoraki","year":"2021","journal-title":"Cytometry A"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154495_bb0235","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010089","article-title":"Roles and mechanisms of long non-coding RNAs in breast cancer","volume":"24","author":"Su","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154495_bb0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154495_bb0250","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41419-018-0882-5","article-title":"Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p\/GSK3\u03b2 signal pathway","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154495_bb0255","first-page":"589","article-title":"YY1-activated long noncoding RNA SNHG5 promotes glioblastoma cell proliferation through p38\/MAPK signaling pathway","volume":"34","author":"Chen","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12282-021-01281-6","article-title":"LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299","volume":"29","author":"Huang","year":"2022","journal-title":"Breast Cancer"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154495_bb0265","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1002\/jcp.28767","article-title":"Assessment of the expression pattern of mTOR-associated lncRNAs and their genomic variants in the patients with breast cancer","volume":"234","author":"Taherian-Esfahani","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154495_bb0270","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2174\/0115680096282865240111055640","article-title":"The prognostic value and clinical significance of lncRNA SNHG5 expression in patients with multiple malignancies: a bioinformatic and meta-analysis","volume":"24","author":"Pashirzad","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1152672","article-title":"The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms","volume":"14","author":"Rezaee","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0280","article-title":"Exosomal lncRNAs as regulators of breast cancer chemoresistance and metastasis and their potential use as biomarkers","volume":"14 - 2024","author":"Blancas-Zugarazo","year":"2024","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154495_bb0285","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12282-024-01574-6","article-title":"Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression","volume":"31","author":"Chen","year":"2024","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood-2014-07-589069","article-title":"Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia","volume":"125","author":"Audrito","year":"2015","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.ijbiomac.2026.154495_bb0295","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1038\/onc.2015.415","article-title":"NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer","volume":"35","author":"Hong","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118241","article-title":"Multifaceted interactions between lncRNA-associated ceRNA networks and small molecules in triple-negative breast cancer","volume":"189","author":"Alkan","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154495_bb0305","first-page":"1002","article-title":"Exosomal lncRNAs: the newest promising liquid biopsy","volume":"2","author":"Tellez-Gabriel","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1615433","article-title":"Exosomal ncRNAs in liquid biopsy: a new paradigm for early cancer diagnosis and monitoring","volume":"15","author":"Ghani","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0315","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cca.2019.04.082","article-title":"Liquid biopsy: circulating exosomal long noncoding RNAs in cancer","volume":"495","author":"Jiang","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154495_bb0320","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/jmri.28495","article-title":"Challenges and changes of the breast cancer screening paradigm","volume":"57","author":"C\u00f6mert","year":"2023","journal-title":"J. Magn. Reson. Imaging"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154495_bb0325","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0330","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203200","article-title":"Identifying breast cancer subtypes associated modules and biomarkers by integrated bioinformatics analysis","volume":"41","author":"Wang","year":"2021","journal-title":"Biosci. Rep."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154495_bb0335","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.7150\/jca.81430","article-title":"PPAR-\u03b4 as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-\u03b4 as a prognostic biomarker and its association with immune infiltrates in breast cancer","volume":"14","author":"Wang","year":"2023","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154495_bb0340","article-title":"GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer","volume":"14","author":"Yuan","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154495_bb0345","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041668","article-title":"Prognostic and clinicopathological significance of long noncoding RNA SNHG in patients with breast cancer: a systematic review and meta-analysis","volume":"104","author":"Koh","year":"2025","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0350","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s40001-024-01745-3","article-title":"An increase in SNHG5 expression is associated with poor cancer prognosis, according to a meta-analysis","volume":"29","author":"Huang","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.836417","article-title":"Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence","volume":"9","author":"Almansour","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170628","article-title":"A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents","volume":"12","author":"Helwa","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0365","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12951-025-03768-2","article-title":"Advances of extracellular vesicles isolation and detection frontier technology: from heterogeneity analysis to clinical application","volume":"23","author":"Li","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.154495_bb0370","article-title":"Optimization of a method for the clinical detection of serum exosomal miR-940 as a potential biomarker of breast cancer","volume":"12 - 2022","author":"Gu","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154495_bb0375","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13058-016-0753-x","article-title":"Plasma exosome microRNAs are indicative of breast cancer","volume":"18","author":"Hannafon","year":"2016","journal-title":"Breast Cancer Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026044430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026044430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:24:13Z","timestamp":1793917453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026044430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":75,"alternative-id":["S0141813026044430"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154495","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating exosomal long non-coding RNAs NAMPT-Antisense and SNHG5 as emerging biomarkers in breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154495"}}